-
1
-
-
0023092276
-
Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients
-
PMid:3814821
-
Lee JS, Dixon D, Kantarjian H, Keating MJ, Talpaz P. Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients. Blood 1987; 69: 929-936 PMid:3814821
-
(1987)
Blood
, vol.69
, pp. 929-936
-
-
Lee, J.S.1
Dixon, D.2
Kantarjian, H.3
Keating, M.J.4
Talpaz, P.5
-
2
-
-
0028345579
-
Infections in chronic lymphocytic leukemia risks factors and impact on survival and treatment
-
PMid:8049645
-
Molica S. Infections in chronic lymphocytic leukemia risks factors and impact on survival and treatment. Leuk Lymphoma 1994; 13: 203-214 http://dx.doi.org/10.3109/10428199409056283 PMid:8049645
-
(1994)
Leuk Lymphoma
, vol.13
, pp. 203-214
-
-
Molica, S.1
-
3
-
-
0023092276
-
Prognosis of chronic lymphocytic leukemia a multivariate regression analysis of 325 untreated patients
-
PMid:3814821
-
Lee JS, Dixon D, Kantarjian H, Keating MJ and Talpaz P. Prognosis of chronic lymphocytic leukemia a multivariate regression analysis of 325 untreated patients Blood 1987; 69 929-936 PMid:3814821
-
(1987)
Blood
, vol.69
, pp. 929-936
-
-
Lee, J.S.1
Dixon, D.2
Kantarjian, H.3
Keating, M.J.4
Talpaz, P.5
-
4
-
-
0030927872
-
Prophylactic strategies to meet infectious complications in fludarabine-treated CLL
-
PMid:9179282
-
Sudhoff T, Arning M and Schneider W. Prophylactic strategies to meet infectious complications in fludarabine-treated CLL. Leukemia 1997; 11: suppl. 2, S38-S41 PMid:9179282
-
(1997)
Leukemia
, vol.11
, Issue.SUPPL. 2
-
-
Sudhoff, T.1
Arning, M.2
Schneider, W.3
-
5
-
-
0031952390
-
The infectious complications of Chronic Lymphocytic Leukemia
-
PMid:9625391
-
Morrison VA. The infectious complications of Chronic Lymphocytic Leukemia. Sem Oncol 1998; 25: 98-106 PMid:9625391
-
(1998)
Sem Oncol
, vol.25
, pp. 98-106
-
-
Morrison, V.A.1
-
6
-
-
28044461775
-
Intracerebral CSF collection mimicking cerebral abscess in a patient suffering from cryptococcal meningitis
-
PMid:16291277
-
Vakis A, Koutentakis D, Karabetsos D, Ntouros D. Intracerebral CSF collection mimicking cerebral abscess in a patient suffering from cryptococcal meningitis. J Infect 2005; 51: e233-235 http://dx.doi.org/10.1016/j.jinf.2005.02.007 PMid:16291277
-
(2005)
J Infect
, vol.51
-
-
Vakis, A.1
Koutentakis, D.2
Karabetsos, D.3
Ntouros, D.4
-
7
-
-
33747055130
-
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study
-
PMid:16885047
-
Pagano L, Caira M, Candoni A, Offidani M, Fianchi L, Martino B, Pastore D, Picardi M, Bonini A, Chierichini A, Fanci R, Caramatti C, Invernizzi R, Mattei D, Mitra ME, Melillo L, Aversa F, Van Lint MT, Falcucci P, Valentini CG, Girmenia C, Nosari A. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006;91:1068-1075 PMid:16885047
-
(2006)
Haematologica
, vol.1
, pp. 1068-1075
-
-
Pagano, L.1
Caira, M.2
Candoni, A.3
Offidani, M.4
Fianchi, L.5
Martino, B.6
Pastore, D.7
Picardi, M.8
Bonini, A.9
Chierichini, A.10
Fanci, R.11
Caramatti, C.12
Invernizzi, R.13
Mattei, D.14
Mitra, M.E.15
Melillo, L.16
Aversa, F.17
Van Lint, M.T.18
Falcucci, P.19
Valentini, C.G.20
Girmenia, C.21
Nosari, A.22
more..
-
8
-
-
84861418842
-
Hema e-Chart Group, Italy. A prospective survey of febrile events in hematological malignancies
-
PMid:22124621
-
Pagano L, Caira M, Rossi G, Tumbarello M, Fanci R, Garzia MG Vianelli N, Filardi N, De Fabritiis P, Beltrame A, Musso M, Piccin A, Cuneo A, Cattaneo C, Aloisi T, Riva M, Rossi G, Salvadori U, Brugiatelli M, Sannicola S, Morselli M, Bonini A, Viale P, Nosari A, Aversa F; Hema e-Chart Group, Italy. A prospective survey of febrile events in hematological malignancies. Ann Hematol 2012; 91:767-774 http://dx.doi.org/10.1007/s00277-011-1373-2 PMid:22124621
-
(2012)
Ann Hematol
, vol.91
, pp. 767-774
-
-
Pagano, L.1
Caira, M.2
Rossi, G.3
Tumbarello, M.4
Fanci, R.5
Garzia, M.G.6
Vianelli, N.7
Filardi, N.8
De Fabritiis, P.9
Beltrame, A.10
Musso, M.11
Piccin, A.12
Cuneo, A.13
Cattaneo, C.14
Aloisi, T.15
Riva, M.16
Rossi, G.17
Salvadori, U.18
Brugiatelli, M.19
Sannicola, S.20
Morselli, M.21
Bonini, A.22
Viale, P.23
Nosari, A.24
Aversa, F.25
more..
-
9
-
-
81255171499
-
Epidemiological trends in invasive aspergillosis in France the SAIF network (2005-2007)
-
PMid:21668573
-
Lortholary O, Gangneux J-P, Sitbon K, Lebeau B, de Mombrison F, Le Strat Y et al. Epidemiological trends in invasive aspergillosis in France the SAIF network (2005-2007). Clin Microbiol Infect 2011; 17:1882-1889 http://dx.doi.org/10.1111/j.1469-0691.2011.03548.x PMid:21668573
-
(2011)
Clin Microbiol Infect
, vol.17
, pp. 1882-1889
-
-
Lortholary, O.1
Gangneux, J.-P.2
Sitbon, K.3
Lebeau, B.4
de Mombrison, F.5
Le Strat, Y.6
-
10
-
-
78249285274
-
The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients
-
PMid:20947312
-
Perkhofer S, Lass-Flor C, Hell M, Russ G, Krause R, Honigl M et al. The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. Int J Antimicr Ag 2010; 36:531-536 http://dx.doi.org/10.1016/j.ijantimicag.2010.08.010 PMid:20947312
-
(2010)
Int J Antimicr Ag
, vol.36
, pp. 531-536
-
-
Perkhofer, S.1
Lass-Flor, C.2
Hell, M.3
Russ, G.4
Krause, R.5
Honigl, M.6
-
11
-
-
84867336299
-
Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry
-
PMid:22898389
-
Steinbach WJ, Marr KA, Anaissie EJ, Azie N, Quan SP, Meier-Kriesche HU et al. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. J Infect 2012; 65:453-464 http://dx.doi.org/10.1016/j.jinf.2012.08.003 PMid:22898389
-
(2012)
J Infect
, vol.65
, pp. 453-464
-
-
Steinbach, W.J.1
Marr, K.A.2
Anaissie, E.J.3
Azie, N.4
Quan, S.P.5
Meier-Kriesche, H.U.6
-
12
-
-
24944503543
-
Multiple lines of chemotherapy are the main risk factor for severe infections in patients with chronic lymphocytic leukemia with febrile episodes
-
PMid:16079122
-
Molteni A, Nosari A, Montillo M, Cafro A, Klersy C, Morra E. Multiple lines of chemotherapy are the main risk factor for severe infections in patients with chronic lymphocytic leukemia with febrile episodes. Haematologica 2005; 90: 1145-1147 PMid:16079122
-
(2005)
Haematologica
, vol.90
, pp. 1145-1147
-
-
Molteni, A.1
Nosari, A.2
Montillo, M.3
Cafro, A.4
Klersy, C.5
Morra, E.6
-
13
-
-
0041660844
-
Disease activity and pre-treatment rather than ipogammaglobulinemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukemia
-
PMid:12899715
-
Hensael M, Kornaker M, Yammeni S, Egerer G, Ho AD. Disease activity and pre-treatment rather than ipogammaglobulinemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukemia. Br J Haematol 2003; 122: 600-606 http://dx.doi.org/10.1046/j.1365-2141.2003.04497.x PMid:12899715
-
(2003)
Br J Haematol
, vol.122
, pp. 600-606
-
-
Hensael, M.1
Kornaker, M.2
Yammeni, S.3
Egerer, G.4
Ho, A.D.5
-
14
-
-
2342436930
-
Pneumocystis carinii pneumonia in chronic lymphocytic leukemia
-
PMid:15082848, PMCid:1742966
-
Vavricka SR, Halter J, Hechelhammer L, Himmelmann A. Pneumocystis carinii pneumonia in chronic lymphocytic leukemia. Postgrad Med J 2004; 80 :236-238 http://dx.doi.org/10.1136/pgmj.2003.012252 PMid:15082848 PMCid:1742966
-
(2004)
Postgrad Med J
, vol.80
, pp. 236-238
-
-
Vavricka, S.R.1
Halter, J.2
Hechelhammer, L.3
Himmelmann, A.4
-
15
-
-
22044443115
-
Extrapulmonary tuberculous abscess in chronic lymphocytic leukemia treated with fludarabine: case report and review of literature
-
PMid:15981223
-
Leung WH, Tsang SF, Chim CS. Extrapulmonary tuberculous abscess in chronic lymphocytic leukemia treated with fludarabine: case report and review of literature. Am J Hematol 2005; 79: 246-247 http://dx.doi.org/10.1002/ajh.20322 PMid:15981223
-
(2005)
Am J Hematol
, vol.79
, pp. 246-247
-
-
Leung, W.H.1
Tsang, S.F.2
Chim, C.S.3
-
16
-
-
0026744046
-
Infections and serum IgG levels in patients with chronic lymphocytic leukemia
-
PMid:1644158
-
Itola M, Helenius H, Nikoskelaien J and Remes K. Infections and serum IgG levels in patients with chronic lymphocytic leukemia. Eur J Haematol 1992; 48 266-270. PMid:1644158
-
(1992)
Eur J Haematol
, vol.48
, pp. 266-270
-
-
Itola, M.1
Helenius, H.2
Nikoskelaien, J.3
Remes, K.4
-
17
-
-
58149243238
-
Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia
-
PMid:18176848
-
Alexandrescu DT, Wiernik PH. Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia. Med Oncol 2008; 25: 309-314 http://dx.doi.org/10.1007/s12032-007-9037-8 PMid:18176848
-
(2008)
Med Oncol
, vol.25
, pp. 309-314
-
-
Alexandrescu, D.T.1
Wiernik, P.H.2
-
18
-
-
0027979004
-
Immunoglobulin replacement in patients with chronic lymphocytic leukaemia a comparison of two dose regimens
-
PMid:7803248
-
Chapel H, Dicato M, Gamm H, Brennan V, Ries F, Bunch C and Lee M. Immunoglobulin replacement in patients with chronic lymphocytic leukaemia a comparison of two dose regimens. Br J Haematol 1994; 88 209-212. http://dx.doi.org/10.1111/j.1365-2141.1994.tb05002.x PMid:7803248
-
(1994)
Br J Haematol
, vol.88
, pp. 209-212
-
-
Chapel, H.1
Dicato, M.2
Gamm, H.3
Brennan, V.4
Ries, F.5
Bunch, C.6
Lee, M.7
-
19
-
-
43749104030
-
Tumor-derived IL-6 may contribute to the immunological defect in CLL
-
PMid:17972945
-
Buggins AG, Patten PE, Richards J, et al. Patten PE, Richards J, Thomas NS, Mufti GJ, Devereux S. Tumor-derived IL-6 may contribute to the immunological defect in CLL. Leukemia 2008; 22: 1084-1087 http://dx.doi.org/10.1038/sj.leu.2405015 PMid:17972945
-
(2008)
Leukemia
, vol.22
, pp. 1084-1087
-
-
Buggins, A.G.1
Patten, P.E.2
Richards, J.3
Patten, P.E.4
Richards, J.5
Thomas, N.S.6
Mufti, G.J.7
Devereux, S.8
-
20
-
-
0019934873
-
Abonormal T-lymphocyte subpopolations in patients with B cell chronic lymphocytic leukemia an analysis by monoclonal antibodies
-
PMid:6214590
-
Platsoucas CD, Galinski M, Kempin S, Reich L, Clarkcon B and Good RA. Abonormal T-lymphocyte subpopolations in patients with B cell chronic lymphocytic leukemia an analysis by monoclonal antibodies. J Immunol 1982; 129 2305-2312 PMid:6214590
-
(1982)
J Immunol
, vol.129
, pp. 2305-2312
-
-
Platsoucas, C.D.1
Galinski, M.2
Kempin, S.3
Reich, L.4
Clarkcon, B.5
Good, R.A.6
-
21
-
-
0029901196
-
Functional abnormalities in granulocytes predict susceptibility to bacterial infections in chronic lymphocitic leukemia
-
Itala M, Vainio O, Remes K. Functional abnormalities in granulocytes predict susceptibility to bacterial infections in chronic lymphocitic leukemia. Eur J Haematol 1996; 57: 46-53 http://dx.doi.org/10.1111/j.1600-0609.1996.tb00489.x
-
(1996)
Eur J Haematol
, vol.57
, pp. 46-53
-
-
Itala, M.1
Vainio, O.2
Remes, K.3
-
22
-
-
0018354333
-
Monocyte and granulocyte defect in chronic lymphocytic leukemia
-
PMid:219699, PMCid:2042293
-
Zeya HI, Keku E, Richards F and Spurr CL. Monocyte and granulocyte defect in chronic lymphocytic leukemia. Am J Pathol 1979; 95 43-54 PMid:219699 PMCid:2042293
-
(1979)
Am J Pathol
, vol.95
, pp. 43-54
-
-
Zeya, H.I.1
Keku, E.2
Richards, F.3
Spurr, C.L.4
-
23
-
-
0021949085
-
Defective complement activity in CLL
-
PMid:3845763
-
Heath M, Cheson BD. Defective complement activity in CLL. Am J Hematol 1985; 19: 63-73 http://dx.doi.org/10.1002/ajh.2830190109 PMid:3845763
-
(1985)
Am J Hematol
, vol.19
, pp. 63-73
-
-
Heath, M.1
Cheson, B.D.2
-
24
-
-
0028333904
-
The management of chronic lymphocytic leukemia at a single centre over a 24 year period prognostic factors for survival
-
PMid:7515019
-
Karmiris T, Rohatiner AZ, Love S, Carter M, Ganjoo RK, Amess J, Norton AJ, Lister TA. The management of chronic lymphocytic leukemia at a single centre over a 24 year period prognostic factors for survival. Haematol Oncol 1994; 12 (1) 29-39 http://dx.doi.org/10.1002/hon.2900120105 PMid:7515019
-
(1994)
Haematol Oncol
, vol.12
, Issue.1
, pp. 29-39
-
-
Karmiris, T.1
Rohatiner, A.Z.2
Love, S.3
Carter, M.4
Ganjoo, R.K.5
Amess, J.6
Norton, A.J.7
Lister, T.A.8
-
25
-
-
0035880884
-
Impact of therapy with chlorambucil, fludarabine or fludarabine plus chlorambucil on infections in patients with chronic lymphocitic leukemia: Intergroup Study Cancer and Leukemia Group B 9011
-
PMid:11504743
-
Morrison VA, Rai K, Peterson BL, Kolitz JE, Elias L, Appelbaum FR, Hines JD, Shepherd L, Martell RE, Larson RA, Schiffer CA. Impact of therapy with chlorambucil, fludarabine or fludarabine plus chlorambucil on infections in patients with chronic lymphocitic leukemia: Intergroup Study Cancer and Leukemia Group B 9011. J Clin Oncol 2001; 19: 3611-3621 PMid:11504743
-
(2001)
J Clin Oncol
, vol.19
, pp. 3611-3621
-
-
Morrison, V.A.1
Rai, K.2
Peterson, B.L.3
Kolitz, J.E.4
Elias, L.5
Appelbaum, F.R.6
Hines, J.D.7
Shepherd, L.8
Martell, R.E.9
Larson, R.A.10
Schiffer, C.A.11
-
26
-
-
0034649696
-
Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia
-
PMid:11114313
-
Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, Hines J, Threatte GA, Larson RA, Cheson BD Schiffer CA. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med 2000: 343: 1750-1757 http://dx.doi.org/10.1056/NEJM200012143432402 PMid:11114313
-
(2000)
N Engl J Med
, vol.343
, pp. 1750-1757
-
-
Rai, K.R.1
Peterson, B.L.2
Appelbaum, F.R.3
Kolitz, J.4
Elias, L.5
Shepherd, L.6
Hines, J.7
Threatte, G.A.8
Larson, R.A.9
Cheson, B.D.10
Schiffer, C.A.11
-
27
-
-
70349330220
-
Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia
-
PMid:19652068
-
Knauf WU, Lissichkov T, Aldaoud A, Liberati A, Loscertales J, Herbrecht R, Juliusson G, Postner G, Gercheva L, Goranov S, Becker M, Fricke H-J, Huguet F, Del Giudice I, Klein P, Tremmel L, Merkle K, Montillo M. Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia. J Clin Oncol 2009; 27: 4378-4384 http://dx.doi.org/10.1200/JCO.2008.20.8389 PMid:19652068
-
(2009)
J Clin Oncol
, vol.27
, pp. 4378-4384
-
-
Knauf, W.U.1
Lissichkov, T.2
Aldaoud, A.3
Liberati, A.4
Loscertales, J.5
Herbrecht, R.6
Juliusson, G.7
Postner, G.8
Gercheva, L.9
Goranov, S.10
Becker, M.11
Fricke, H.-J.12
Huguet, F.13
Del Giudice, I.14
Klein, P.15
Tremmel, L.16
Merkle, K.17
Montillo, M.18
-
28
-
-
70350720141
-
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia
-
German CLL Study Group. PMid:19605849
-
Eichorst BF, Busch R, Stilgerbauer S, Stauch M, Bergmann MA, Ritgen M, Kranzhofer N, Rohrberg R, Soling U, Burkhard O, Weste3rmann A, Goede V, Schweighofer CD, Fisher K, Fink AM, Wendtner, rittinger G, Dohner H, Emmerich B, Hallek M and the German CLL Study Group. First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia. Blood 2009; 114: 3382-3391 PMid:19605849
-
(2009)
Blood
, vol.114
, pp. 3382-3391
-
-
Eichorst, B.F.1
Busch, R.2
Stilgerbauer, S.3
Stauch, M.4
Bergmann, M.A.5
Ritgen, M.6
Kranzhofer, N.7
Rohrberg, R.8
Soling, U.9
Burkhard, O.10
Westermann, A.11
Goede, V.12
Schweighofer, C.D.13
Fisher, K.14
Fink, A.M.W.15
Brittinger, G.16
Dohner, H.17
Emmerich, B.18
Hallek, M.19
-
29
-
-
0033771581
-
Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukemia
-
PMid:11086646
-
Krebs T, Zimmerli S, Bodmer T, Lammle B. Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukemia. J Intern Med 2000; 248: 343-348 http://dx.doi.org/10.1046/j.1365-2796.2000.00730.x PMid:11086646
-
(2000)
J Intern Med
, vol.248
, pp. 343-348
-
-
Krebs, T.1
Zimmerli, S.2
Bodmer, T.3
Lammle, B.4
-
30
-
-
27144548424
-
Efficacy of bendamustine in patients with relapsed or refractory chronic limphocytic leukemia: results of a phase I/II study of the German CLL Study Group
-
PMid:16219572
-
Bergmann M, Goebeler ME, Herold M, Emmerich B, Wilhelm M, Ruelfs C, Boening L, Hallek MJ. Efficacy of bendamustine in patients with relapsed or refractory chronic limphocytic leukemia: results of a phase I/II study of the German CLL Study Group. Haematologica 2005; 90: 1357-1364 PMid:16219572
-
(2005)
Haematologica
, vol.90
, pp. 1357-1364
-
-
Bergmann, M.1
Goebeler, M.E.2
Herold, M.3
Emmerich, B.4
Wilhelm, M.5
Ruelfs, C.6
Boening, L.7
Hallek, M.J.8
-
31
-
-
80053020928
-
Bendamustine combined with rituximab in patients with relapsed or refractory chronic limphocytic leukemia: a multicenter phase II trial of the German CLL Study Group
-
PMid:21844497
-
Fisher K, Cramer P, Busch R, Stilgenbauer S, Bahlo J, Schweighofer CD, Bottcher S, Staib P Kihel M, Eckart MJ, Kranz G, Goede V, Elter T, Buhler A, Winkler D, Kneba M, Dohner HEichhorst BF, Hallek M Wendtner C-M. Bendamustine combined with rituximab in patients with relapsed or refractory chronic limphocytic leukemia: a multicenter phase II trial of the German CLL Study Group. J Clin Oncol 2011;29: 3559-3566 http://dx.doi.org/10.1200/JCO.2010.33.8061 PMid:21844497
-
(2011)
J Clin Oncol
, vol.9
, pp. 3559-3566
-
-
Fisher, K.1
Cramer, P.2
Busch, R.3
Stilgenbauer, S.4
Bahlo, J.5
Schweighofer, C.D.6
Bottcher, S.7
Staib, P.8
Kihel, M.9
Eckart, M.J.10
Kranz, G.11
Goede, V.12
Elter, T.13
Buhler, A.14
Winkler, D.15
Kneba, M.16
Dohner, H.17
Eichhorst, B.F.18
Hallek, M.19
Wendtner, C.-M.20
more..
-
32
-
-
0028999305
-
Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies A role for Pneumocystis carinii pneumonia prophylaxis
-
PMid:7771465
-
Byrd JC, Hargis JB, Kester KE, Hospenthal DR, Knutson SW and Diehl LF. Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies A role for Pneumocystis carinii pneumonia prophylaxis. Am J Hematol 1995; 49 135-145 http://dx.doi.org/10.1002/ajh.2830490207 PMid:7771465
-
(1995)
Am J Hematol
, vol.49
, pp. 135-145
-
-
Byrd, J.C.1
Hargis, J.B.2
Kester, K.E.3
Hospenthal, D.R.4
Knutson, S.W.5
Diehl, L.F.6
-
33
-
-
31544434508
-
Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia
-
the German CLL Study Group. PMid:16219797
-
Eichorst BF, Busch R, Hopfinger G, Pasold R, Hensel M, Steinbrecher C, Siehl S, Jager U, Bergmann M, Stilgenbauer S, Schweighofer C, Wendtner CM, Dohner H, Brittinger G, Emmerich B, Hallek M and the German CLL Study Group. Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia. Blood 2006; 107: 885-891 http://dx.doi.org/10.1182/blood-2005-06-2395 PMid:16219797
-
(2006)
Blood
, vol.107
, pp. 885-891
-
-
Eichorst, B.F.1
Busch, R.2
Hopfinger, G.3
Pasold, R.4
Hensel, M.5
Steinbrecher, C.6
Siehl, S.7
Jager, U.8
Bergmann, M.9
Stilgenbauer, S.10
Schweighofer, C.11
Wendtner, C.M.12
Dohner, H.13
Brittinger, G.14
Emmerich, B.15
Hallek, M.16
-
34
-
-
34447530283
-
on behalf of the UK National Cancer Research Institute Hematological Oncology Clinical Studies Group and NCRI Chronic Lymphocytic Leukemia Working Group. Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukemia (the LRF CLL4 Trial): a randomized controlled trial
-
Catovsky D, Richards S, Matutes E, Oscier D, Dyer MJS, Bezares RF, Pettitt AR, Hamblin T, Milligan DW, Child JA, Hamilton MS, Dearden CE, Smith AG, Bosanquet AG, Davis Z, Brito-Babapulle V, Else M, Wade R, Hillmen P on behalf of the UK National Cancer Research Institute Hematological Oncology Clinical Studies Group and NCRI Chronic Lymphocytic Leukemia Working Group. Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukemia (the LRF CLL4 Trial): a randomized controlled trial. Lancet 2007: 370 :230-239 http://dx.doi.org/10.1016/S0140-6736(07)61125-8
-
(2007)
Lancet
, vol.370
, pp. 230-239
-
-
Catovsky, D.1
Richards, S.2
Matutes, E.3
Oscier, D.4
Dyer, M.J.S.5
Bezares, R.F.6
Pettitt, A.R.7
Hamblin, T.8
Milligan, D.W.9
Child, J.A.10
Hamilton, M.S.11
Dearden, C.E.12
Smith, A.G.13
Bosanquet, A.G.14
Davis, Z.15
Brito-Babapulle, V.16
Else, M.17
Wade, R.18
Hillmen, P.19
-
35
-
-
33947541773
-
Phase III trial of of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E29976
-
PMid:17283364
-
Flinn IW, Neuberg DS, Grever MR, Dewald GW, BennetJM, Paietta EM, Hussein MA, Appelbaum FR, Larson RA, Mooore DF, Tallman MS. Phase III trial of of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E29976. J Clin Oncol 2007; 25: 793-798 http://dx.doi.org/10.1200/JCO.2006.08.0762 PMid:17283364
-
(2007)
J Clin Oncol
, vol.25
, pp. 793-798
-
-
Flinn, I.W.1
Neuberg, D.S.2
Grever, M.R.3
Dewald, G.W.4
Bennet, J.M.5
Paietta, E.M.6
Hussein, M.A.7
Appelbaum, F.R.8
Larson, R.A.9
Mooore, D.F.10
Tallman, M.S.11
-
36
-
-
0035282055
-
Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia
-
PMid:11230486
-
O' Brien S, Kantarjian HM, Cortes J, Beran M, Koller C, Giles FJ, lerner S, keating M. Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia. J Clin Oncol 2001; 19: 1414-1420 PMid:11230486
-
(2001)
J Clin Oncol
, vol.19
, pp. 1414-1420
-
-
O'Brien, S.1
Kantarjian, H.M.2
Cortes, J.3
Beran, M.4
Koller, C.5
Giles, F.J.6
Lerner, S.7
Keating, M.8
-
37
-
-
77951628255
-
Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the polish adult leukemia group (PALG-CLL3 Study)
-
PMid:20212251
-
Robak T, Jamroziak K, Gora-Tibor J, Stella Holowiecka B, Konopka L, Ceglarek B, Warzocha K, Seferynska I, Piszcz J, calbecka M, Kostyra A, Dwilewicz-Trojaczek J, Dmoszynska A, Zawilska K, Hellmann A, Zdunczyk A, Potoczek S, Piotrowska M, Lewandowski K, Blonski JZ. Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the polish adult leukemia group (PALG-CLL3 Study). J Clin Oncol 2010; 28:1863-1869 http://dx.doi.org/10.1200/JCO.2009.25.9630 PMid:20212251
-
(2010)
J Clin Oncol
, vol.28
, pp. 1863-1869
-
-
Robak, T.1
Jamroziak, K.2
Gora-Tibor, J.3
Stella Holowiecka, B.4
Konopka, L.5
Ceglarek, B.6
Warzocha, K.7
Seferynska, I.8
Piszcz, J.9
Calbecka, M.10
Kostyra, A.11
Dwilewicz-Trojaczek, J.12
Dmoszynska, A.13
Zawilska, K.14
Hellmann, A.15
Zdunczyk, A.16
Potoczek, S.17
Piotrowska, M.18
Lewandowski, K.19
Blonski, J.Z.20
more..
-
38
-
-
0036839469
-
Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia
-
PMid:12384407
-
Shulz H, Klein SK, Rehwald U, Reiser M, Hinke A, Knauf WU, et al. Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia. Blood 2002; 100:3115-3120 http://dx.doi.org/10.1182/blood-2002-03-0972 PMid:12384407
-
(2002)
Blood
, vol.100
, pp. 3115-3120
-
-
Shulz, H.1
Klein, S.K.2
Rehwald, U.3
Reiser, M.4
Hinke, A.5
Knauf, W.U.6
-
39
-
-
77957664665
-
Addition of rituximab to fludarabine and cyclofosfamide in patients with chronic lymphocytic leukemia: a randomised, open-label, phase 3 trial
-
on behalf of international group of investigators and the German Chronic Lymphocytic Leukemia Study Group
-
Hallek M, Fisher K, Fingerle-Rowson G, Fink AM, Bush R, Mayer J, Hensel M, Hopfinger G, Hess G, von grunhagen W, Bergmann M, Catalana J, Zinzani PL, Caligaris-Cappio F, Seymour JF, Berrebi A, Jager U, Cazin B, Trneny M, Westermann A, Wendtner CM; Eichorst BF, Staib P, Buhler A, Winkler D, Zenz T, Bottcher S, Ritgen M, Mendila M, Kneba M, Dohner H, Stingelbauer S, on behalf of international group of investigators and the German Chronic Lymphocytic Leukemia Study Group. Addition of rituximab to fludarabine and cyclofosfamide in patients with chronic lymphocytic leukemia: a randomised, open-label, phase 3 trial. Lancet 2010; 376:1164-1174 http://dx.doi.org/10.1016/S0140-6736(10)61381-5
-
(2010)
Lancet
, vol.376
, pp. 1164-1174
-
-
Hallek, M.1
Fisher, K.2
Fingerle-Rowson, G.3
Fink, A.M.4
Bush, R.5
Mayer, J.6
Mensel, M.7
Hopfinger, G.8
Hess, G.9
von grunhagen, W.10
Bergmann, M.11
Catalana, J.12
Zinzani, P.L.13
Caligaris-Cappio, F.14
Seymour, J.F.15
Berrebi, A.16
Jager, U.17
Cazin, B.18
Trneny, M.19
Westermann, A.20
Wendtner, C.M.21
Eichorst, B.F.22
Staib, P.23
Buhler, A.24
Winkler, D.25
Zenz, T.26
Bottcher, S.27
Ritgen, M.28
Mendila, M.29
Kneba, M.30
Dohner, H.31
Stingelbauer, S.32
more..
-
40
-
-
23044501404
-
Chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab for relapsed and refractory chronic lymphocytic leukemia
-
PMid:15767647
-
Wierda W, O' Brien S, Wen S, Faderl S, Garcia-Manero G, Thomas D, Do KA, Cortes J, Koller C, Beran M, Ferrajoli A, Giles F, Lerner S, Albitar M, Kantarjian H, Keating M. Chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab for relapsed and refractory chronic lymphocytic leukemia. J Clin Oncol 2005; 23: 4070-4078 http://dx.doi.org/10.1200/JCO.2005.12.516 PMid:15767647
-
(2005)
J Clin Oncol
, vol.23
, pp. 4070-4078
-
-
Wierda, W.1
O'Brien, S.2
Wen, S.3
Faderl, S.4
Garcia-Manero, G.5
Thomas, D.6
Do, K.A.7
Cortes, J.8
Koller, C.9
Beran, M.10
Ferrajoli, A.11
Giles, F.12
Lerner, S.13
Albitar, M.14
Kantarjian, H.15
Keating, M.16
-
41
-
-
81255129068
-
Progressive multifocal leukoencephalopathy: an unespected complication of modern therapeutic monoclonal antibody teraphies
-
PMid:22082208
-
Tavazzi E, Ferrante P, Khalili K. Progressive multifocal leukoencephalopathy: an unespected complication of modern therapeutic monoclonal antibody teraphies. Clin Microbiol Infect 2011; 17: 1776-1780 http://dx.doi.org/10.1111/j.1469-0691.2011.03653.x PMid:22082208
-
(2011)
Clin Microbiol Infect
, vol.17
, pp. 1776-1780
-
-
Tavazzi, E.1
Ferrante, P.2
Khalili, K.3
-
42
-
-
10444276466
-
Infectious toxicity using alemtuzumab
-
PMid:15590388
-
Nosari A, Montillo M, Morra E. Infectious toxicity using alemtuzumab. Haematologica 2004; 89: 1415-1419 PMid:15590388
-
(2004)
Haematologica
, vol.89
, pp. 1415-1419
-
-
Nosari, A.1
Montillo, M.2
Morra, E.3
-
43
-
-
37649004407
-
Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia
-
PMid:17984186
-
Hillmen P, Skotnicki AB, Robak T, Jaksic B, Dmoszynska A, Wu J, Sirard C, Mayer J. Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia. J Clin Oncol 2007; 25: 5616-5623 http://dx.doi.org/10.1200/JCO.2007.12.9098 PMid:17984186
-
(2007)
J Clin Oncol
, vol.25
, pp. 5616-5623
-
-
Hillmen, P.1
Skotnicki, A.B.2
Robak, T.3
Jaksic, B.4
Dmoszynska, A.5
Wu, J.6
Sirard, C.7
Mayer, J.8
-
44
-
-
40849100404
-
Characteristics and stage of the underlying diseases could determine the risk of opportunistic infections in patients receiving alemtuzumab
-
PMid:18245646
-
Nosari A, Tedeschi A, RicciF, Montillo M. Characteristics and stage of the underlying diseases could determine the risk of opportunistic infections in patients receiving alemtuzumab. Haematologica 2008; 93: e30-31 http://dx.doi.org/10.3324/haematol.12465 PMid:18245646
-
(2008)
Haematologica
, vol.93
-
-
Nosari, A.1
Tedeschi, A.2
Ricci, F.3
Montillo, M.4
-
45
-
-
0029937765
-
Humanized CD52 monoclonal antibody Campath-1H as line treatment in chronic lymphocytic leukemia
-
Mellstedt H for the European Study Group of Campath-1H treatment in CLL.
-
Osterborg A, Dyer MJS, Bunjes D, Pangalis GA, Bastion Y, Catovsky D, Mellstedt H for the European Study Group of Campath-1H treatment in CLL. Humanized CD52 monoclonal antibody Campath-1H as line treatment in chronic lymphocytic leukemia. Br J Haematol 1996; 93: 151-153 http://dx.doi.org/10.1046/j.1365-2141.1996.450989.x
-
(1996)
Br J Haematol
, vol.93
, pp. 151-153
-
-
Osterborg, A.1
Dyer, M.J.S.2
Bunjes, D.3
Pangalis, G.A.4
Bastion, Y.5
Catovsky, D.6
-
46
-
-
0037092951
-
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study
-
PMid:11986207
-
Keating MJ, Flinn I, Vinay J, Binet JL, Hillmen P, Byrd J, Albitar M, Brettman L, Santabarbara P, Wacker B, Rai KR. Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study. Blood 2002; 99: 3554-3561 http://dx.doi.org/10.1182/blood.V99.10.3554 PMid:11986207
-
(2002)
Blood
, vol.99
, pp. 3554-3561
-
-
Keating, M.J.1
Flinn, I.2
Vinay, J.3
Binet, J.L.4
Hillmen, P.5
Byrd, J.6
Albitar, M.7
Brettman, L.8
Santabarbara, P.9
Wacker, B.10
Rai, K.R.11
-
47
-
-
0037106502
-
Alemtuzumab in previously treated chronic lymphocytic leukaemia patients who also had received fludarabine
-
PMid:12228210
-
Rai KR, Freter CE, Mercier RJ, Cooper MR, Mitchell BS, Stadtmauer EA, Santabarbara P, Wacker B, Brettman L. Alemtuzumab in previously treated chronic lymphocytic leukaemia patients who also had received fludarabine. J Clin Oncol 2002; 20: 3891-3897 http://dx.doi.org/10.1200/JCO.2002.06.119 PMid:12228210
-
(2002)
J Clin Oncol
, vol.20
, pp. 3891-3897
-
-
Rai, K.R.1
Freter, C.E.2
Mercier, R.J.3
Cooper, M.R.4
Mitchell, B.S.5
Stadtmauer, E.A.6
Santabarbara, P.7
Wacker, B.8
Brettman, L.9
-
48
-
-
27244451794
-
Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of phase II trial
-
PMid:16145065
-
Elter T, Borchmann P, Schulz H, Reiser M, Trelle S, Schnell R, Jensen M, Staib P, Schink the T, Sttzer H, Rech J, Gramatzki M, Aulitzky W, Hasan I, Josting A, Hallek M, Engert A. Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of phase II trial. J Clin Oncol 2005; 23: 7024-7031 http://dx.doi.org/10.1200/JCO.2005.01.9950 PMid:16145065
-
(2005)
J Clin Oncol
, vol.23
, pp. 7024-7031
-
-
Elter, T.1
Borchmann, P.2
Schulz, H.3
Reiser, M.4
Trelle, S.5
Schnell, R.6
Jensen, M.7
Staib, P.8
Schink, T.9
Sttzer, H.10
Rech, J.11
Gramatzki, M.12
Aulitzky, W.13
Hasan, I.14
Josting, A.15
Hallek, M.16
Engert, A.17
-
49
-
-
82555169679
-
Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukemia: a randomised phase 3 trial
-
Elter T, Gercheva- Kyukukova L, Pylylpenko H, Robak T, Jaksic B, Rekhtman G, G, Kyrcz-Krzemien S, Vatutin M, Wu J, Sirard C, Hallek M, Engert A. Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukemia: a randomised phase 3 trial. Lancet Oncol 2011; 12: 1204-1213 http://dx.doi.org/10.1016/S1470-2045(11)70242-X
-
(2011)
Lancet Oncol
, vol.12
, pp. 1204-1213
-
-
Elter, T.1
Gercheva-Kyukukova, L.2
Pylylpenko, H.3
Robak, T.4
Jaksic, B.5
Rekhtman, G.6
Kyrcz-Krzemien, S.7
Vatutin, M.8
Wu, J.9
Sirard, C.10
Hallek, M.11
Engert, A.12
-
50
-
-
79959840618
-
Alemtuzumab:what is the secret to safe therapy?
-
PMid:21685865
-
Elter T, Hallek M, Montillo M. Alemtuzumab:what is the secret to safe therapy?. Clin Adv Hematol Oncol 2011;9:364-373 PMid:21685865
-
(2011)
Clin Adv Hematol Oncol
, vol.9
, pp. 364-373
-
-
Elter, T.1
Hallek, M.2
Montillo, M.3
-
51
-
-
84875991863
-
-
Polish Lymphoma Research Group Web site Geisler C. HOVO68 CLL protocol: annual safety report PMid:20194866
-
Polish Lymphoma Research Group Web site Geisler C. HOVO68 CLL protocol: annual safety report 2008. http.//www.plrg.pl/images/stories/badania/hovon/HOVON68CLL_Annual_Safety_Report_2008.pdf PMid:20194866
-
(2008)
-
-
-
52
-
-
77950502126
-
Ofatumumab as single agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia
-
PMid:16618945
-
Wierda WG, Kipps TJ, Mayer J, Stilgenbauer S, Williams CD, Hellmann A, et al. Ofatumumab as single agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia. J Clin Oncol 2010;28: 1749-1755 http://dx.doi.org/10.1200/JCO.2009.25.3187 PMid:16618945
-
(2010)
J Clin Oncol
, vol.8
, pp. 1749-1755
-
-
Wierda, W.G.1
Kipps, T.J.2
Mayer, J.3
Stilgenbauer, S.4
Williams, C.D.5
Hellmann, A.6
-
53
-
-
33744793781
-
Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia
-
PMid:20697069 PMCid:2988639
-
Montillo M, Tedeschi A, Miqueleiz S, Veronese S, Intropido L, Ricci F, Colosimo A, Scarpati B, Montagna M, Nichelatti M, Regazzi M, Morra E. Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia. J Clin Oncol 2006; 24: 2337-2342 http://dx.doi.org/10.1200/JCO.2005.04.6037 PMid:20697069 PMCid:2988639
-
(2006)
J Clin Oncol
, vol.24
, pp. 2337-2342
-
-
Montillo, M.1
Tedeschi, A.2
Miqueleiz, S.3
Veronese, S.4
Intropido, L.5
Ricci, F.6
Colosimo, A.7
Scarpati, B.8
Montagna, M.9
Nichelatti, M.10
Regazzi, M.11
Morra, E.12
-
54
-
-
78650017999
-
Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101
-
PMid:21670470
-
Lin TS, Donohue K A, Byrd JC, Lucas MS, Hoke EE, Bengtson EM, Rai KR, Atkins JN, Link BK, Larson RA. Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101. J Clin Oncol 2010; 28: 4500-4506 http://dx.doi.org/10.1200/JCO.2010.29.7978 PMid:21670470
-
(2010)
J Clin Oncol
, vol.28
, pp. 4500-4506
-
-
Lin, T.S.1
Donohue, K.A.2
Byrd, J.C.3
Lucas, M.S.4
Hoke, E.E.5
Bengtson, E.M.6
Rai, K.R.7
Atkins, J.N.8
Link, B.K.9
Larson, R.A.10
-
55
-
-
80052188111
-
Cyclophosphamide, fludarabine, alemtuzumab and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia
-
PMid:23090186 PMCid:3478266
-
Badoux XC, Keating MJ, Wang X, O' Brien S, Ferrajoli A, Faderl S, Burger J, Koller C, Lerner S, Kantarjian H, Wierda WG. Cyclophosphamide, fludarabine, alemtuzumab and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia. Blood 2011; 118: 2085-2093 http://dx.doi.org/10.1182/blood-2011-03-341032 PMid:23090186 PMCid:3478266
-
(2011)
Blood
, vol.118
, pp. 2085-2093
-
-
Badoux, X.C.1
Keating, M.J.2
Wang, X.3
O'Brien, S.4
Ferrajoli, A.5
Faderl, S.6
Burger, J.7
Koller, C.8
Lerner, S.9
Kantarjian, H.10
Wierda, W.G.11
-
56
-
-
35148849255
-
The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who failed alemtuzumab or have bulky adenopathy
-
PMid:21498674
-
Tam CS, O' Brien S, Lerner S, Khouri I, Ferrajoli A, Faderl S, Browning M, Tsimberidou AM, Kantarjian H, Wierda WG. The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who failed alemtuzumab or have bulky adenopathy. Leuk Lymph 2007; 48:1931-1939 http://dx.doi.org/10.1080/10428190701573257 PMid:21498674
-
(2007)
Leuk Lymph
, vol.48
, pp. 1931-1939
-
-
Tam, C.S.1
O'Brien, S.2
Lerner, S.3
Khouri, I.4
Ferrajoli, A.5
Faderl, S.6
Browning, M.7
Tsimberidou, A.M.8
Kantarjian, H.9
Wierda, W.G.10
-
57
-
-
79959190996
-
Chemotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia
-
Russell Ca on behalf of the 407 Study Investigators.PMid:9758577
-
Wierda WG, Kipps TJ, Durig J, Griskevicius L, Stilgenbauer S, Mayer J, Smolej L, Hess G, Griniute R, Hernandez-Ilizaliturri FJ, Padmanabhan S, Gorczyca M, Chang C, Chan G, Gupta I, Nielsen TG and Russell Ca on behalf of the 407 Study Investigators. Chemotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia. Blood 2011; 117: 6450-6458 PMid:9758577
-
(2011)
Blood
, vol.117
, pp. 6450-6458
-
-
Wierda, W.G.1
Kipps, T.J.2
Durig, J.3
Griskevicius, L.4
Stilgenbauer, S.5
Mayer, J.6
Smolej, L.7
Hess, G.8
Griniute, R.9
Hernandez-Ilizaliturri, F.J.10
Padmanabhan, S.11
Gorczyca, M.12
Chang, C.13
Chan, G.14
Gupta, I.15
Nielsen, T.G.16
-
58
-
-
0032189459
-
Infections in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approach to prophylaxis
-
PMid:3317855
-
Anaissie E, Kontoyiannis DP, O' Brien S, Kantarjian H, Robertson L, Lerner S, Keating M. Infections in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approach to prophylaxis. Ann Intern Med 1998; 129:559-566 PMid:3317855
-
(1998)
Ann Intern Med
, vol.129
, pp. 559-566
-
-
Anaissie, E.1
Kontoyiannis, D.P.2
O'Brien, S.3
Kantarjian, H.4
Robertson, L.5
Lerner, S.6
Keating, M.7
-
59
-
-
0023428147
-
mechanisms of infection inchronic lymphocytic leukemia
-
PMid:2901668
-
Chapel HM and Bunch C. mechanisms of infection inchronic lymphocytic leukemia. Semin Hematol 1987; 24 291-296 PMid:2901668
-
(1987)
Semin Hematol
, vol.24
, pp. 291-296
-
-
Chapel, H.M.1
Bunch, C.2
-
60
-
-
0023764718
-
Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia
-
Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia, PMid:12651283
-
Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia. Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. N Engl J Med 1988; 319: 902-907 http://dx.doi.org/10.1056/NEJM198810063191403 PMid:12651283
-
(1988)
N Engl J Med
, vol.319
, pp. 902-907
-
-
-
61
-
-
0038605668
-
Successful treatment with voriconazole of cerebral asperillosis in an hematologic patient
-
ECR05
-
Marbello L, Nosari A, Carrafiello G, Anghilieri M, Cesana C, Cafro AM, D'Avanzo G, Morra E. Successful treatment with voriconazole of cerebral asperillosis in an hematologic patient. Haematologica 2003; 88: (03)ECR05
-
(2003)
Haematologica
, vol.88
, Issue.3
-
-
Marbello, L.1
Nosari, A.2
Carrafiello, G.3
Anghilieri, M.4
Cesana, C.5
Cafro, A.M.6
D'Avanzo, G.7
Morra, E.8
-
62
-
-
0001736301
-
Antibody response to pneumococcal immunization in patients with chronic lymphocytic leukemia
-
Jacobson DR, Ballard HS, Silber R, Ripps CS, Smith JA and Schiffman GS. Antibody response to pneumococcal immunization in patients with chronic lymphocytic leukemia. Blood 1988; 72 (suppl 1): 205a
-
(1988)
Blood
, vol.72
, Issue.SUPPL. 1
, pp. 205
-
-
Jacobson, D.R.1
Ballard, H.S.2
Silber, R.3
Ripps, C.S.4
Smith, J.A.5
Schiffman, G.S.6
|